BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29171080)

  • 21. Symptomatic benefits of testosterone treatment in patient subgroups: a systematic review, individual participant data meta-analysis, and aggregate data meta-analysis.
    Hudson J; Cruickshank M; Quinton R; Aucott L; Wu F; Grossmann M; Bhasin S; Snyder PJ; Ellenberg SS; Travison TG; Brock GB; Gianatti EJ; van der Schouw YT; Emmelot-Vonk MH; Giltay EJ; Hackett G; Ramachandran S; Svartberg J; Hildreth KL; Antonic KG; Tenover JL; Tan HM; Ho Chee Kong C; Tan WS; Marks LS; Ross RJ; Schwartz RS; Manson P; Roberts SA; Skovsager Andersen M; Velling Magnussen L; Aceves-Martins M; Gillies K; Hernández R; Oliver N; Dhillo WS; Bhattacharya S; Brazzelli M; Jayasena CN
    Lancet Healthy Longev; 2023 Oct; 4(10):e561-e572. PubMed ID: 37804846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of testosterone supplementation on sexual function in hypogonadal men with erectile dysfunction.
    Mulhall JP; Valenzuela R; Aviv N; Parker M
    Urology; 2004 Feb; 63(2):348-52; discussion 352-3. PubMed ID: 14972487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased sexual desire with exogenous testosterone administration in men with obstructive sleep apnea: a randomized placebo-controlled study.
    Melehan KL; Hoyos CM; Yee BJ; Wong KK; Buchanan PR; Grunstein RR; Liu PY
    Andrology; 2016 Jan; 4(1):55-61. PubMed ID: 26610430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormonal supplementation and erectile dysfunction.
    Aversa A; Isidori AM; Greco EA; Giannetta E; Gianfrilli D; Spera E; Fabbri A
    Eur Urol; 2004 May; 45(5):535-8. PubMed ID: 15082192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency.
    Boyanov MA; Boneva Z; Christov VG
    Aging Male; 2003 Mar; 6(1):1-7. PubMed ID: 12809074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Baseline Total Testosterone Level on Successful Treatment of Sexual Dysfunction in Men Taking Once-Daily Tadalafil 5 mg for Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia: An Integrated Analysis of Three Randomized Controlled Trials.
    Mulhall JP; Brock GB; Glina S; Baygani S; Donatucci CF; Maggi M
    J Sex Med; 2016 May; 13(5):843-51. PubMed ID: 27017071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of androgen receptor CAG polymorphism on sexual function recovery after testosterone therapy in late-onset hypogonadism.
    Tirabassi G; Corona G; Biagioli A; Buldreghini E; delli Muti N; Maggi M; Balercia G
    J Sex Med; 2015 Feb; 12(2):381-8. PubMed ID: 25443437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study).
    Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P; Saghir A;
    Int J Clin Pract; 2014 Feb; 68(2):203-15. PubMed ID: 24355040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testosterone therapy and other treatment modalities for female sexual dysfunction.
    Ingram CF; Payne KS; Messore M; Scovell JM
    Curr Opin Urol; 2020 May; 30(3):309-316. PubMed ID: 32205812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Demographic and Clinical Correlates of Patient-Reported Improvement in Sex Drive, Erectile Function, and Energy With Testosterone Solution 2.
    Wu F; Zitzmann M; Heiselman D; Donatucci C; Knorr J; Patel AB; Kinchen K
    J Sex Med; 2016 Aug; 13(8):1212-9. PubMed ID: 27329542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS).
    Khera M; Bhattacharya RK; Blick G; Kushner H; Nguyen D; Miner MM
    J Sex Med; 2011 Nov; 8(11):3204-13. PubMed ID: 21834870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testosterone and sexual function.
    Fugh-Berman A; Scialli AR
    Curr Opin Urol; 2017 Nov; 27(6):516-518. PubMed ID: 28795961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention and management of postprostatectomy sexual dysfunctions part 2: recovery and preservation of erectile function, sexual desire, and orgasmic function.
    Salonia A; Burnett AL; Graefen M; Hatzimouratidis K; Montorsi F; Mulhall JP; Stief C
    Eur Urol; 2012 Aug; 62(2):273-86. PubMed ID: 22575910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sexual function rehabilitation of men with pituitary tumors].
    Rozhivanov RV; Kurbatov DG
    Urologiia; 2010; (4):48, 50-3. PubMed ID: 20973135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement of sexual function in men with late-onset hypogonadism treated with testosterone only.
    Yassin AA; Saad F
    J Sex Med; 2007 Mar; 4(2):497-501. PubMed ID: 17367445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testosterone treatment in the aging male: myth or reality?
    Nigro N; Christ-Crain M
    Swiss Med Wkly; 2012; 142():w13539. PubMed ID: 22430839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin Receptor Blockers for Erectile Dysfunction in Hypertensive Men: A Brief Meta-Analysis of Randomized Control Trials.
    Ismail SB; Noor NM; Hussain NHN; Sulaiman Z; Shamsudin MA; Irfan M
    Am J Mens Health; 2019; 13(6):1557988319892735. PubMed ID: 31795911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Critical Update of the 2010 Endocrine Society Clinical Practice Guidelines for Male Hypogonadism: A Systematic Analysis.
    Seftel AD; Kathrins M; Niederberger C
    Mayo Clin Proc; 2015 Aug; 90(8):1104-15. PubMed ID: 26205546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels.
    Cunningham GR; Stephens-Shields AJ; Rosen RC; Wang C; Bhasin S; Matsumoto AM; Parsons JK; Gill TM; Molitch ME; Farrar JT; Cella D; Barrett-Connor E; Cauley JA; Cifelli D; Crandall JP; Ensrud KE; Gallagher L; Zeldow B; Lewis CE; Pahor M; Swerdloff RS; Hou X; Anton S; Basaria S; Diem SJ; Tabatabaie V; Ellenberg SS; Snyder PJ
    J Clin Endocrinol Metab; 2016 Aug; 101(8):3096-104. PubMed ID: 27355400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Testosterone Solution 2% on Ejaculatory Dysfunction in Hypogonadal Men.
    Maggi M; Heiselman D; Knorr J; Iyengar S; Paduch DA; Donatucci CF
    J Sex Med; 2016 Aug; 13(8):1220-6. PubMed ID: 27436077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.